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a  b  s  t  r  a  c  t
A  31  year-old  woman  presented  with  acute  pain  on  the  left  side  of  the  thorax  and  abdomen,  radiating  to
the  back  together  with  fever,  after  she  had  returned  from  traveling  in  Southeast  Asia.  Except  for  pleural
friction  rub  auscultated  on  the  left  hemithorax,  no  physical  abnormalities  were  detected.  We diagnosedccepted 28 June 2013
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a classical  course  of Bornholm  disease,  caused  by  an  echovirus  type  1. While  described  as  a  classical
pathogen  causing  Bornholm  disease,  this  genotype  has  not  been  reported  frequently  in Surveillance  data
in  the  Western  World.
© 2013 Elsevier B.V. All rights reserved.ornholm disease
. Why  this case is important
Echoviruses are members of the Enterovirus genus, of which
ore than 200 types have been described [1,2]. Enteroviruses (EVs)
re associated with a wide spectrum of clinical diseases, ranging
rom aseptic meningitis, (myelo)encephalitis, myopericarditis and
eonatal sepsis to Bornholm disease (epidemic pleurodynia), rash
nd upper respiratory tract infection. Infections with EVs occur
orldwide, both as sporadic infections and as outbreaks. They are
ransmitted from person to person mainly by the fecal-oral route
2].
A classical course of Bornholm disease, caused by an echovirus
ype 1 is described here. Textbooks report echovirus 1 infection
o be a classical cause of Bornholm disease, yet most recent lit-
rature dates back to the late 1960s [3,4]. Bornholm disease is a
yositis involving muscles of the thorax and upper abdomen, gen-
rally caused by coxsackievirus B (CBV), less frequently caused by
Abbreviations: BP, base pairs; CFR, complement ﬁxation reaction; CBV,
oxsackievirus B; CAV, coxsackievirus A; EV, enterovirus; IVIG, intravenous
mmunoglobulin; nAbs, neutralizing antibodies; PCR, polymerase chain reaction;
IVM, National Institute of Public Health and the Environment; VP, viral protein;
NA, ribonucleic acid; 5′ UTR, 5′ untranslated region.
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386-6532/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.jcv.2013.06.039echovirus types 1, 6, 8, 9 and 19 [3–6], and coxsackievirus A (CAV)
types 4, 6, 9 and 10 [7].
Diagnostic data from the Academic Medical Center Amsterdam,
showed no detection of echovirus 1 for at least a decade [8] (and
unpublished observations). Similarly, national surveillance data,
dating back to the mid60s, show echovirus 1 to account for <0.1%
of all EV types isolated in the Netherlands [9].
2. Case description
A, previously healthy, 31 year-old woman presented at our hos-
pital in Amsterdam in January 2012, two days after she had returned
from a 1 month during backpacking holiday to Thailand, Indonesia
(Sulawesi) and Malaysia. She had developed fever with chills and
acute pain of the left hemithorax and abdomen, radiating to her
back. The pain increased when she inhaled.
One week earlier she had experienced a comparable, although
milder, episode on the other side of her body. Between the episodes,
there was a continuous slight feeling of pain. On  physical exami-
nation, a moderately ill (painful with breathing), neither anemic
nor jaundiced woman was  seen. On examining the lungs, pleural
friction rub was  auscultated on the left side. There were no further
localizing symptoms.
Initial laboratory tests yielded a hemoglobin of 8.2 mmol/L
(7.5–8.7 mmol/L), white blood cell count of 12.9 × 109 L−1
(4–10.5 × 109 L–1) with increase of neutrophils, thrombocytes
of 385 × 109 L–1 (150–400 × 109 L–1) and C-reactive protein of
20.6 mg/L (5 mg/L). Liver enzymes and creatinine were within
the normal range. Malaria was  excluded by thick blood smear.
All other tests, including chest X-ray and urinalysis, showed no
M. Leendertse et al. / Journal of Clinic
Table 1
Neutralization assays of the patients’ echovirus type 1.
Enterovirus type CAV6 Echovirus 1
IVIG batch and year Titer
IVIG 1 2005 16 8
IVIG  2 2008 32 4
IVIG  3 2009 16 8
IVIG  4 2010 32 8
Korean IVIG 2011 32 8
Patients’ serum T = 0 4
Patients’ serum T = 13d 64
Echovirus 1 was isolated from patients’ stool and brought into culture. Neutraliza-
tion assays of this isolate were performed in which 100 TCID50 of virus isolate was
incubated with 4 different batches of IVIG, dating 2005–2010, and one Korean batch.
A  coxsackievirus A6 (CAV6) strain was used as positive assay control. Additionally, a
neutralization assay was  performed with patients’ own serum taken at day 0 (T = 0)
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ond 13 days later (T = 13d) and the patients’ echovirus 1. A titer ≤1:8 is considered
egative.
bnormalities. A computerized tomography scan did not show
ung emboli. Differentially, Bornholm disease was considered.
fter one month, her complaints had improved, she hardly had
ny painful episodes and on examination the pleural rub had
isappeared.
As Bornholm disease was one of the possible diagnoses, feces
nd serology were sent for EV testing. EV RNA was detected in
tool, by 5′ untranslated region (UTR) PCR [10]. Additionally, a
eroconversion for enterovirus antibodies was found in two  sera
ith a 13 days interval (<1:8–1:64), using a complement ﬁxa-
ion reaction (CFR, Virion/Serion, Clindia Benelux b.v., Almere, the
etherlands). Feces were cultured on different cell lines [8]: RD
rhabdomyosarcoma cells), HT29 (human colon carcinoma cells),
MK  (tertiary monkey kidney cells), HEL (human embryonic lung
ells), A549 (human lung ﬁbroblast cells) and Vero cells. All cell lines
eveloped an enterovirus cytopathic effect, except the RD cell line.
or subsequent serotyping with human enterovirus-speciﬁc horse
ntisera pools A-G and H-R (RIVM, Bilthoven, the Netherlands) [1].
xpecting a CBV, ﬁnding echovirus 1 was rather surprising. This
nding was conﬁrmed by genotyping of a 350–400 bp sequence
ragment of the viral protein (VP)1 gene (GenBank accession num-
er: KC816737), both directly from the feces sample as well as
rom the isolated virus [8]. Sequences were aligned to human EV
eference strains for typing [11]. Presence of neutralizing anti-
odies (nAbs) in the patients serum was tested by neutralization
ssay (Table 1) [12], in which we used the echovirus 1 isolated
rom the patients’ feces. The patients’ convalescence serum, taken
 weeks after start of the ﬁrst symptoms, showed neutraliza-
ion of the virus (1:64), in contrast to the ﬁrst serum, taken one
eek after the onset of symptoms (<1:8). Previously, we showed
Ab titers against highly and moderately prevalent enterovirus
ypes in intravenous immunoglobulin (IVIG) [1]. To see whether
chovirus 1 is circulating at a higher frequency than expected from
he surveillance data, we tested 4 batches of Dutch IVIG (Sanquin,
msterdam, the Netherlands) and 1 batch of Asian IVIG (a kind
ift of dr. Rogier van Doorn, Oxford University, Ho Chi Minh City,
ietnam). We  included CAV6 as a recently circulating type, and
ndeed moderate nAb titers can be found against CAV6. However,
one of the IVIG batches tested contained nAbs against echovirus
 (≤1:8).
We additionally performed a phylogenetic analysis of the
atients’ echovirus strain by comparing it to available echovirus
 sequences published in GenBank. Most strains were isolated
n China and India and for the largest part formed geograph-
cally distinct monophyletic clusters. The patients’ strain was
ound to be genetically related to strains isolated in India
Fig. 1) depicting an Asian origin, rather than a Western
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3. Other similar and contrasting cases in literature
In literature, echovirus 1 is described as a well-known cause
of Bornholm disease. All literature, though, refers to only two
manuscripts written in the late 1960s and early 1970s [3,4].
Only one of these manuscripts described an epidemic of Born-
holm disease caused by echovirus 1, amongst British servicemen
and women  in Aden (Yemen) in 1967 [4]. After this epidemic,
no further reports on echovirus 1 associated Bornholm disease
were described. Although echovirus 1 is mentioned as a classi-
cal pathogen causing Bornholm disease, recent literature does not
provide evidence that echovirus 1 is an important cause of Born-
holm disease in the Western World.
Furthermore, surveillance data indicate that echovirus 1 is an
infrequently detected enterovirus. In the Netherlands, the surveil-
lance system on EV types dates back to 1959, after the introduction
of vaccination against poliovirus. A recent study by Van der Sanden
et al. [9], shows that echovirus 1 has been isolated rarely in the
Dutch surveillance; <0.1% of all EV isolated. Comparable surveil-
lance systems worldwide show a comparably low echovirus 1
isolation rate: in the US, echovirus 1 comprised 0.4% of all EVs
reported to the National Enterovirus Surveillance System in the
period from 1970 to 2005 and, and 0.6% in a national surveillance
system in the UK from 1974 to 1994 [13,14]. Sporadic publications
from surveillance systems in Asian countries (Japan, Taiwan, Korea)
and from Tunisia in Africa, also showed that echovirus 1 was rarely
isolated [15–19]. Unfortunately, there are no general systematic
data on enterovirus surveillance in Asia, neither from Thailand,
Indonesia, or Malaysia. We  did a recent literature review on this
subject, from which a paper is under submission (V.A. Janes et al.)
4. Discussion
In this report we describe a patient with a classical presen-
tation of Bornholm disease, a myositis involving muscles of the
thorax and upper abdomen, caused by enteroviruses, typically by
the CBV group. In our patient, however, the disease was  caused by
echovirus 1, a close relative of CBV, which was  cultured from the
stools and conﬁrmed by PCR and direct genotyping. A seroconver-
sion was  demonstrated for speciﬁc echovirus 1 neutralizing Abs in
the patients’ sera.
Our patient traveled to Thailand and subsequently to Indonesia
(Sulawesi) and Malaysia. Phylogenetic analysis shows the patients’
strain to be closely related to Indian strains, suggesting an Asian
origin. Unfortunately, sequence data of other echovirus 1 strains
circulating in the Asian continent besides China and India are lack-
ing to determine an exact phylogenetic origin and possible spread
of echovirus 1 in that region.
Echovirus 1 is an infrequently reported EV type in the West-
ern World. One could argue that echovirus 1 is underreported in
the different national surveillance systems, as people infected by
echovirus 1 only display mild symptoms and medical help is not
sought [17]. However, nAbs against echovirus 1 are not detected in
IVIG, conﬁrming the surveillance ﬁndings that echovirus 1 is not a
frequently circulating EV type.
In conclusion, our patient got infected with an echovirus 1 caus-
ing a classical episode of Bornholm disease. In textbooks, echovirus
1 is referred to as a classical cause of Bornholm disease, but has only
been reported once in the late 1960s in Bornholm patients in Yemen
[4]. Furthermore, a review of the literature providing these data, in
combination with surveillance data and the fact that speciﬁc nAbs
are absent in IVIG (obtained from >1000 donors per batch in the
Netherlands and Korea) argue against echovirus 1 being a classi-
cal Bornholm disease-causing pathogen. More likely, echovirus 1
can cause occasional outbreaks in different regions of the world.
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Fig. 1. Phylogenetic analysis of the patients’ echovirus type 1. VP1 based neighbor joining tree showing the relationship of the echovirus 1 pleurodynia associated strain
(KC816737/NL/2012/50329) from our patient (indicated in red) to echovirus 1 VP1 sequences published in Genbank; (date 20-9-12). The strains published in Genbank are
coded  by accession number/country/year of isolation/isolate name; IN = India (green), AS = Australia, CH = China (blue), US = United States, AF = Africa, EG = Egypt, SW = Sweden,
(  from 
s
P
s
i
F–)  = not speciﬁed. Phylogenetic tree was constructed by neighbor joining method
oftware package; only values >70% are shown.
ossibly, an outbreak with echovirus 1 happened in Malaysia this
ummer, making it more likely that an accidental tourist became
nfected.unding
None.1000 samplings of maximum-composite-likelihood distances using the MEGA4.0
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